Credit: National Cancer Institute, National Institutes of HealthHalfway into fiscal year 2024, NCI officials are crunching numbers, trying to find ways to live with an appropriation that, for the first time since sequestration, reduces the institute’s spending power.
The NCI Board of Scientific Advisors unanimously approved two new concepts and three reissued concepts at a meeting March 20.
Addressing the NCI Board of Scientific Advisors, Institute Director Kimryn Rathmell announced two key initiatives—the Cancer Screening Research Network and the Virtual Clinical Trials Office—designed to achieve large reductions in cancer mortality and support the cancer research enterprise.
U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
Soon after he was diagnosed with a dedifferentiated liposarcoma, C. Norman Coleman reached out to The Cancer Letter and the Cancer History Project to initiate a series of interviews about his life and career.
We had the privilege of working with Norm Coleman in the International Cancer Expert Corps (ICEC), the NGO he founded in 2013 and where he served as the Senior Scientific Advisor (an approved outside activity from his work at the NCI).
Tempus has sent de-identified tumor profiles with limited associated clinical information from more than 3,000 cancer diagnoses to the NCI.
President Joe Biden has requested an increase of $871.5 million to the overall NIH budget in FY25. Of that amount, $522 million, or nearly 60%, is slated for NCI.
NCI and Cancer Research UK awarded $125 million in total funding through the Cancer Grand Challenges program, supporting research on cancer inequities, early-onset cancers, solid tumors in children, and T-cell receptors. The $125 million investment marks the Cancer Grand Challenges program’s largest funding round to date.
Rutgers Cancer Institute of New Jersey, together with RWJBarnabas Health, the state’s only NCI-designated Comprehensive Cancer Center, was redesignated by NCI.
